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The Genomic Basis of Lactobacilli
as Health-Promoting Organisms
ELISA SALVETTI and PAUL W. O’TOOLE
School of Microbiology and APC Microbiome Institute, University College Cork, Ireland
ABSTRACT Lactobacilli occupy a unique position in human
culture and scientiﬁc history. Like brewer’s and baker’s yeast,
lactobacilli have been associated with food production and
preservation for thousands of years. Lactobacillus species
are used in mixed microbial cultures, such as the classical
Lactobacillus bulgaricus/Streptococcus thermophilus inoculum
for yogurt fermentation, or combinations of diverse lactobacilli/
yeasts in keﬁr grains. The association of lactobacilli consumption
with greater longevity and improved health formed the basis
for developing lactobacilli as probiotics, whose market has
exploded worldwide in the past 10 years. The decade that
followed the determination of the ﬁrst genome sequence of
a food-associated species, Lactobacillus plantarum, saw the
application to lactobacilli of a full range of functional genomics
methods to identify the genes and gene products that govern
their distinctive phenotypes and health associations. In this
review, we will brieﬂy remind the reader of the range of
beneﬁcial eﬀects attributed to lactobacilli, and then explain the
phylogenomic basis for the distribution of these traits across
the genus. Recognizing the strain speciﬁcity of probiotic eﬀects,
we review studies of intraspeciﬁc genomic variation and their
contributions to identifying probiotic traits. Finally we oﬀer a
perspective on classiﬁcation of lactobacilli into new genera in a
scheme that will make attributing probiotic properties to clades,
taxa, and species more logical and more robust.
BENEFICIAL EFFECTS ASSOCIATED
WITH LACTOBACILLI
The genusLactobacillus includes 177 species (http://www
.bacterio.net/lactobacillus.html): they are non-spore-
forming, mostly nonmotile, and rod-shaped (although
coccobacilli are observed). They generally have a fermen-
tative metabolism (although genome sequence analysis
has provided evidence of potential for respiration [1])
with lactic acid as the main fermentation product.
Lactobacilli grow in rich carbohydrate-containing
substrates such as food (dairy products, grain products,
meat and ﬁsh products, beer, wine, fruits and fruit juices,
pickled vegetables, mash, sauerkraut, silage, and sour-
dough), water, soil, and sewage; they are part of the
microbiota associated with the mouth and gastrointes-
tinal and genital tracts of humans and many animals (2).
With regard to their beneﬁcial and protechnologi-
cal properties, 35 Lactobacillus species have Qualiﬁed
Presumption of Safety (QPS) status from the European
Food Safety Authority (EFSA) (3) and 12 species are
Generally Recognized as Safe (GRAS) by the FDA (http://
www.accessdata.fda.gov/scripts/fdcc/?set=GRASNotices).
Lactobacilli constitute 43% (84 species) of the total
number of microorganisms with certiﬁed beneﬁcial use
(195 species representing 28 genera of phyla Actino-
bacteria, Firmicutes, and Proteobacteria) (4), with 22 of
them represented by strains that are patented in Europe
due to their potential probiotic properties (E. Salvetti
and P. W. O’Toole, under revision).
Given the rising importance of lactobacilli as beneﬁ-
cial microbes, the focus of the present review is the
genetic and genomic basis of health promotion by
lactobacilli. A comprehensive survey of the discovery
research that ﬁrst identiﬁed these features is beyond the
scope of this review, and the reader is referred to ex-
cellent recent surveys on this topic including Lebeer et al.
(5) and Papadimitriou et al. (6).
Received: 12 January 2017, Accepted: 21 February 2017,
Published: 23 June 2017
Editors: Robert Allen Britton, Baylor College of Medicine, Houston,
TX, and Patrice D. Cani, Université catholique de Louvain, Brussels,
Belgium
Citation: Salvetti E, O’Toole PW. 2017. The genomic basis of
lactobacilli as health-promoting organisms. Microbiol Spectrum
5(3):BAD-0011-2016. doi:10.1128/microbiolspec.BAD-0011-2016.
Correspondence: Paul W. O’Toole, pwotoole@ucc.ie
© 2017 American Society for Microbiology. All rights reserved.
ASMscience.org/MicrobiolSpectrum 1
Downloaded from www.asmscience.org by
IP:  143.239.102.117
On: Mon, 20 Aug 2018 12:37:34
Beneﬁcial effects associated with lactobacilli, which
have been the subject of decades of research, may be
classiﬁed into three broad categories—in vivo survival
mechanisms, in vivo colonization mechanisms, and di-
rect effects on the host (see Table 1 for representative
examples). Arguably, only effects on the host are true
“probiotic” traits, as deﬁned recently by Hill et al. (7),
but because surviving intestinal transit is probably re-
quired to exert beneﬁcial effects, work aimed at devel-
oping probiotic strains and identifying probiotic features
has traditionally included survival and colonization
analysis, as well as metabolic adaptation to nutritional
substrates typically available in the mammalian intes-
tine. A fourth category, effect on the intestinal micro-
biota, has recently been formalized (8), although exerting
a direct effect on other microbes such as pathogens has
always been a recognized potential probiotic trait (5).
A preponderance of the literature on probiotic mode
of action in lactobacilli is based on studies performed
in vitro or in preclinical models, as distinct from in hu-
mans or in animals. As a consequence, there are many
features and gene products whose actual contribution
to probiotic function in lactobacilli is unclear. This is
reﬂected in the lack of success in obtaining EFSA ap-
proval for probiotics and functional foods, mainly linked
to insufﬁcient characterization of the food and poor
scientiﬁc support for the claimed effect (9), the absence
of a beneﬁcial physiological effect based on the scien-
tiﬁc evidence assessed (10), and the nonrecognition of
the property of preventing, treating, or curing a human
disease with food (11).
In reviewing the literature at this juncture (Fig. 1),
a clear stalling in investment in Lactobacillus probiotic
research is apparent, reﬂected in the large knowledge
gap in molecular mechanisms that still needs to be ﬁlled.
GENOMIC DIVERSITY OF LACTOBACILLI
The genome sequences of almost all Lactobacillus type
strains and some historically associated genera were
recently determined (12, 13), providing the deﬁnitive
genomic framework for mining all relevant phyloge-
netic and functional information and corroborating
the genetic basis of what had been described for nearly
a century, namely the extreme phenotypic diversity of
lactobacilli (2, 14).
Comparative analysis (12, 13) uncovered the ex-
traordinary level of genomic diversity of the lactobacilli:
the sizes of the genomes, in fact, range from 1.23 Mb to
4.91 Mb (four times larger) and the DNA GC content
range is from 31.93 to 57.02%. The overall level of
genome difference among the members of the Lactoba-
cillus genus was found to be comparable to that between
members of a bacterial family (12). Even more aston-
ishing is consideration of the pairwise average nucle-
otide identity values that are comparable for those
between members of taxonomic orders or classes (12).
The genus as currently deﬁned is polyphyletic, meaning
it encompasses the descendants of several most re-
cent common ancestors (MRCAs), speciﬁcally those of
Pediococcus, Weissella, Leuconostoc, Oenococcus, and
Fructobacillus. The overall signiﬁcance of this unusually
complex phylogenomic landscape is that it makes for
a challenging research context. In comparison with
studies of pathogens, for example, where comparative
genomics has led to discovery of pathogenicity islands
TABLE 1 Selected examples of probiotic traits in lactobacilli
Category Host beneﬁt Representative examples and eﬀectors Reference
In vivo survival Viable bacteria reach site of
action in the gut.
Acid resistance in L. plantarum by ATPases 93
Bile resistance in L. salivarius by bile salt hydrolases 94
Bacteria can metabolize dietary
ingredients.
Metabolic diversity of intestinal lactobacilli 12
In vivo adherence Maintaining bacterial numbers
and close host cell association
Bioﬁlm formation in L. reuteri 100-23 76
Aggregation of L. crispatus cells during murine colonization 95
Aggregation and adhesion protein allowing colonization by L. gasseri 96
Production of bacterial surface adhesins 31, 97
Direct eﬀects on host Altered cellular or organ
functions
Alteration of signal transduction, apoptosis and barrier function in
epithelial cells by L. rhamnosus LGG proteins
98, 99
Alteration of innate immune cell function by L. acidophilus S-layer protein 100
Suppression of inﬂammation in colitis by histamine produced by L. reuteri 101
Degradation of proinﬂammatory cytokines by L. casei 32
Altered cytokine production due to L. rhamnosus pili 36
Eﬀect on microbiota
or pathogens
Restores normal microbiota
or excludes pathogens
Anti-Listeria monocytogenes activity of L. salivarius bacteriocin 88
Controversial eﬀects of probiotics on the human gut microbiota 102
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and converting bacteriophages, such discovery para-
digms are less helpful in lactobacilli, with the exception
of the cobalamin biosynthesis/propanediol utilization
island of Lactobacillus reuteri (15, 16). The imminent
reallocation of the members of the current genus Lac-
tobacillus across a number of smaller, genomically more
cohesive new genera (Salvetti et al., in preparation) will
provide a more sensible context for genotype-phenotype
matching in the lactobacilli.
It is reasonable to expect to be able to understand the
interaction of Lactobacillus species and their respective
environments in the context of their genomic related-
ness and genome content. A simple hypothesis is that the
MRCAs of all the lactobacilli had a large genome with
diverse metabolic capability, and that adaptive radiation
to the range of niches occupied by contemporary species
was marked by gene loss in those species whose niche
is nutrient-rich like the mammalian body or fermented
foods, and clade-speciﬁc gene acquisition in some clades.
DISTRIBUTION OF PROBIOTIC-RELATED
TRAITS IN LACTOBACILLI
Despite these challenges, we and others have been
mining the wealth of genomic data for lactobacilli to
catalog the number and distribution of traits linked
with probiotic function including those in Table 1.
These analyses are ongoing (E. Salvetti et al., in prepa-
ration), but our initial observations are already in-
structive. The data provide a framework for testing the
well-recognized phenomenon (17) of strain speciﬁcity of
probiotic effects, and for using comparative genomics
and genome annotation mining to uncover probiotic
traits in other species. The outcome of analyses based on
comparative genomics within species is discussed further
below.
Carbohydrate Metabolism
Lactobacilli are saccharolytic but devote a lower
proportion of their coding capacity to carbohydrate
degradation than, for example, biﬁdobacteria (18) or
Bacteroides spp. (19), even in the larger-genome species
such as L. plantarum (20). High-throughput annotation
of 213 genomes identiﬁed glycosyl hydrolases corres-
ponding to 48 of the 133 families of glycoside hydrolases
(GHs) in the CAZy database (http://www.cazy.org)
(12). Newly identiﬁed enzymes included an endo-α-N-
acetylgalactosaminidase in L. brantae and L. perolens
that may be involved in mucus utilization and could thus
be a colonization factor. Glycosyl hydrolase family 95
(GH95) enzymes had not previously been identiﬁed in
the lactobacilli, but were identiﬁed in L. harbinensis and
L. perolens (12), which were isolated from traditional
fermented vegetables in China and spoiled soft drinks,
respectively. GH95 is a fucosidase, a type of enzyme that
is well recognized in biﬁdobacteria (21), Bacteroides
spp. (22), and Akkermansia muciniphila (23). Although
used by biﬁdobacteria for breaking down human milk
oligosaccharides, most of the evidence suggests that
these fucosidases are used by gut commensals or path-
ogens for metabolizing fucose residues on intestinal
mucus (reviewed in reference 24). The unusually high
FIGURE 1 Publication numbers by year using search terms (lactobacillus probiotic) in
PubMed. Search performed 13 July 2016.
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proportional gene count encoding glycosyl hydrolases
in six Lactobacillus clades (12)—L. (par)alimentarius,
L. perolens, L. plantarum, L. rapi, L. fructivorans,
and Carnobacterium spp.—suggests adaptation of these
clades to the selective pressure typically encountered in
the gut. Members of these clades have been isolated from
the gut of animals (i.e., goat, poultry, and honey bee
stomach) and are used as feed additives or probiotics.
Genomics of Surface Carbohydrate Decoration
The major form of surface carbohydrate in Gram-
positive bacteria, exopolysaccharide (EPS), contributes
to technological features like product viscosity and tex-
ture, but also to host interaction (25–27). In Lacto-
bacillus, EPS production is strain speciﬁc and growth
medium dependent, and the EPS can be bound or re-
leased by the bacterial cell (e.g., 28, 29), making trans-
lation of in vitro ﬁndings to probiotic effects in vivo very
challenging. Genus-wide genome comparison identiﬁed
a number of glycosyltransferases that show restricted
presence across species and that may be relevant for
probiotic function. For example, the L. gasseri genome
harbors a gene encoding GT11 (galactoside α-1,2-L-
fucosyltransferase), and the L. delbrueckii DSM 15996T
encodes GT92 (N-glycan core α-1,6-fucoside β-1,4-
galactosyltransferase). Production of fucose-containing
lipopolysaccharide is an immune-evasion/antigenicmim-
icry strategy of pathogens such as Helicobacter pylori
by virtue of the fucose-containing structures present
in Lewis-type blood group antigens (30), and it will be
interesting to know if lactobacilli use such a strategy
to modulate innate immune interaction. The GT11 en-
zyme is predicted to be encoded by the A. muciniphila
genome, so perhaps this trait is present in other gut
commensals.
Surface Protein Repertoires
Surface proteins are the next topological interaction
layer below EPS on Lactobacillus cells, and they thus
represent an important interface with the external en-
vironment (31). As noted above (Table 1), an extra-
cellular protease of the subtilase type produced by the
L. casei strain present in the commercial probiotic cock-
tail called VSL#3 degrades IP-10, an inﬂammatory me-
diator involved in colitis (32). This appears to be the
only published example of a surface-anchored enzyme
contributing to a probiotic trait in lactobacilli (which is
distinct from probiotic-derived soluble proteins such as
p40 and p75, which have been detected in L. casei group
members [33]). However, cataloging of the repertoire
of this class of protease (lactocepin) in the lactobacilli
identiﬁed 60 genes among 213 genomes, which were
proportionally overrepresented in members of the
L. delbrueckii, L. casei, L. salivarius, and L. buchneri
clades, as well as the carnobacteria. The high level of
sequence divergence found between the predicted lac-
tocepin proteins (12) makes it at least plausible that the
uncharted speciﬁcity of some of these proteases could
include human proteins as targets.
A major class of surface proteins in Gram-positives
is those that are covalently attached to peptidoglycan
by a sortase transpeptidation reaction (34). Search-
ing the translated protein data for the target motifs of
the sortase enzyme identiﬁed the repertoire of sortase-
anchored proteins in the lactobacilli. This identiﬁed
1,628 predicted LPXTG-containing proteins and 357
sortase enzymes in the 213 genomes. Species known
to contain strains identiﬁed as being probiotic did not
harbor unusually high numbers of sortase-anchored
proteins; in fact, the greatest absolute number or
genome-size-normalized number was in the milk isolate
Carnobacterium maltaromaticum. The fact that sortase-
anchored proteins may have almost any biological prop-
erties that cannot always be identiﬁed from their pri-
mary sequence (such as ﬁbrinogen binding, exempliﬁed
in reference 35) makes this a difﬁcult bioprospecting
approach. A more productive screen identiﬁed 67 pilus
gene clusters in 51 Lactobacillus strains, whereby the
pilus gene search was based on the surface structures
identiﬁed as mucin binding and immunomodulatory
in L. rhamnosus GG (36). These clusters were present
in clades and species not known to be probiotic, such as
L. thailandensis, L. ruminis, and L. koreensis, broaden-
ing the avenues of exploration for new beneﬁcial strains.
INTRASPECIFIC DIVERSITY OF
LACTOBACILLUS SPECIES
HARBORING PROBIOTIC STRAINS
Although a number of studies have addressed the simi-
larity and the differences within species of the Lactoba-
cillus genus through comparative genomics, knowledge
of the evolutionary history and the genomic diversity
below the species level is still incomplete. Unraveling the
intraspeciﬁc diversity of lactobacilli is, in fact, funda-
mental for the regulatory perspective, for the develop-
ment of identiﬁcation tools for tracking isolates during
industrial processes, and for the commercial standpoint
to differentiate probiotics or starter cultures (37).
The effects of microbial strains that are marketed as
established probiotics along with their clinical evidence
assessed in clinical studies were recently reviewed by Di
4 ASMscience.org/MicrobiolSpectrum
Salvetti and O’Toole
Downloaded from www.asmscience.org by
IP:  143.239.102.117
On: Mon, 20 Aug 2018 12:37:34
Cerbo et al. (38) and Salvetti et al. (39), and they are
summarized in Table 2.
Data regarding the evolutionary genomics and pop-
ulation structure of species harboring probiotic strains
shown in Table 2 are outlined and reviewed below.
Lactobacillus acidophilus
First described byMoro in 1900,L. acidophilus is one of
the most commonly used microorganisms for dietary
applications and it is available in several foods such as
milk, yogurt, formulas, as well as in dietary supplements
with reported probiotic effects. The probiotics effects
associated with L. acidophilus strains are resistance to
bile and low pH, adhesion to human colonocytes in cell
culture, antimicrobial production, and lactase activity,
which contribute to the mediation of host immune re-
sponse, lowering of serum cholesterol, improving host
lactose metabolism, and preventing or treating infection
(37).
The ﬁrst genome sequence published was from strain
NCFM (40) which led to the identiﬁcation of several
mucus- and ﬁbronectin-binding proteins, implicated in
the adhesion to human intestinal cells, several classes of
transporters which were found to be ﬁnely regulated by
carbohydrate source (induced by their respective sub-
strates but repressed by glucose), likely contributing
to the competitive ability of L. acidophilus in the human
gastrointestinal tract, and nine two-component regula-
tory systems, some of them associated with bacteriocin
production and acid tolerance (40, 37).
An updated population structure of L. acidophilus
based on the comparative analysis of genomic sequences
from 34 isolates showed that this species is monophy-
letic and characterized by a low rate of intraspeciﬁc
diversity, with the commercial isolates identical at the
genome sequence level (41). Although the phenotypic
features of the isolates were diverse (i.e., the effects
on the immune response following oral vaccination in
healthy adults or differences in oxalate depletion), less
variation is detected at the genomic level, in accordance
with what was unraveled by other genotypic analyses
as PCR-ﬁngerprinting assays, randomly ampliﬁed poly-
morphic DNA analysis, and multilocus sequence typing
(MLST). This suggests that commercial use has domes-
ticated L. acidophilus, with genetically stable, invariant
strains being consumed globally by the human popula-
TABLE 2 Species for which strains have been ascribed probiotic properties and related applications (according to references
38 and 39)a
Trait L
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Gastrointestinal mucosa adhesion × × × ×
Cancer × ×
Vaginal and urinary tract disorders × × × × × × × × ×
Hypercholesterolemia × × ×
H. pylori treatment × × × × × × ×
Oxaluria × × ×
Mastitis × × ×
Immunomodulation × × × × × × × × × ×
Gastrointestinal diseases × × × ×
Survival in the gut × × × ×
Diarrhea treatment × × × × × ×
Periodontal disease × × × × ×
Type 2 diabetes mellitus × × × ×
Muscle, bone, and cartilage diseases × ×
Skin disease × × × × × × ×
Ear, nose, and throat diseases × × ×
Respiratory diseases × × × × × × ×
Behavior/mental illness ×
Other × × × × × ×
aAn × means the respective trait has been recorded in that species.
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tion. A limited level of diversity is governed by the var-
iable presence of three prophage remnants, designated
as Potentially Autonomic Units (PAU, observed for the
ﬁrst time in L. acidophilus NCFM genome [40]), and a
region of three contiguous loci with phage-related func-
tions, whose distribution was linked to the isolate his-
tory, as commercial or culture collection derived. No
active prophages were identiﬁed in the panel of strains,
according with the absence of the recent description of
phages active on L. acidophilus strains.
The remarkable genetic stability, supported also
by the absence of extrachromosomal DNA, along with
their effective phage resistance, has likely contributed
to the commercial success of L. acidophilus strains,
allowing manufacturers to maintain quality control of
the cultures for probiotic production and dairy fermen-
tations (41).
Lactobacillus brevis
L. brevis is an obligate heterofermentative Gram-positive
organism that produces CO2 as a side product from
glucose metabolism. Strains of this species were isolated
from plant materials, fermented beverages, and the hu-
man intestinal tract (2).
To date, all genome-based information regard-
ing the intraspeciﬁc diversity of probiotic features in
L. brevis mainly relates to two strains, ATCC 367 and
KB290.
L. brevis ATCC 367 was the ﬁrst L. brevis strain
studied for probiotic features and its genome, sequenced
in 2006 (42), revealed the presence of mucus-binding
proteins and other surface layer proteins, which con-
tribute to the adhesion to epithelial cells and extracel-
lular matrices as ﬁbronectin (31, 43).
The probiotic properties of strain KB290, isolated
from a traditional Japanese fermented vegetable (suguki),
include tolerance to gastrointestinal juices, immune sys-
tem modulation, and gut health improvement (44, 45),
and its genome sequence was reported in 2013 (46).
At the genomic level, the main difference between
the two strains is the presence of nine plasmids in
KB290, which constitute, to date, the highest number
of plasmids ever detected among Lactobacillus species.
The KB290 genome harbors genes for 375 unique pro-
teins, while the ATCC 367 genome harbors genes for
169 unique traits. The majority of unique ATCC 367
genes encode for hypothetical proteins, while, among the
unique genes in the KB290 genome, 177 encode proteins
of known functions such as putative cell surface pro-
teins, which might enhance the utilization of plant ma-
terial, and proteins involved in the biosynthesis of cell
wall-associated polysaccharides, which could contrib-
ute, on one hand, to form a protective shield against host
complement factors in the gastrointestinal tract, and,
on the other hand, trigger the host differential mucosal
responses. The genomic regions harboring these genes
in KB290 have a different DNA GC content compared
to the genome average, indicating that this strain has
undergone events of lateral transfer. This is also sup-
ported by the whole-genome alignment between ATCC
367 and KB290, which revealed huge rearrangements
generated by homologous recombination between mo-
bile elements, extensively distributed in both genomes.
The nine plasmids in KB290 together carry 191 pre-
dicted protein-coding genes (7% of the genome total).
Although harboring plasmids constitutes a metabolic/
ﬁtness cost for host cells, no strains were found lacking
all nine plasmids after plasmid curing attempts, sug-
gesting that the plasmids impart a range of beneﬁcial
features to the host. Genes detected on the plasmids were
involved in conjugation, presumptive cell wall polysac-
charide biosynthesis and stress response (such as multi-
drug resistance transporters, which possibly confer bile
resistance, or DNA protection proteins with ferritin-like
domains that could enhance tolerance to oxidative stress
and reduce lipid oxidation). Stress-inducible proteins
contribute to the survival of probiotic bacteria in the
harsh conditions they encounter in the host and they are
effectively considered probiotic factors (6).
Based on the data reported by Fukao and colleagues
(46), L. brevis is considered as a multiniche bacterium
which, like other lactobacilli, contains genomic regions
of laterally transferred genes; further research is needed
to understand the role of L. brevis plasmids in the gut
(46).
Lactobacillus casei/Lactobacillus paracasei
L. casei and L. paracasei are two phylogenetically
closely related species, both members of the normal
human gut microbiota, used in the food industries as
starter cultures for dairy products or beneﬁcial microbes,
and reported to improve nutrition and to aid disease
prevention and therapy (47).
The high genomic relatedness between these two
species is the reason for the ongoing misidentiﬁcation of
strains belonging to L. casei and L. paracasei: according
to the current valid nomenclature, the majority of the
sequenced L. casei and L. paracasei strains would be
allotted to L. paracasei subsp. paracasei, because all of
them showed >99% identity with L. casei ATCC 334,
which is currently the type strain of L. paracasei subsp.
paracasei (48).
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Given the interchangeable use of L. casei and L. para-
casei names in many publications, the data presented
below will refer to both species.
The evolutionary history of these species has been
visualized through MLST, which showed the strains ra-
diating into three distinct lineages (49), and comparative
genomic hybridization (CGH), which revealed adapta-
tion of these strains to cheese environment through ge-
nome decay of genes involved in carbohydrate utilization
and transcriptional regulation (50).
A ﬁrst comparative genomics analysis of 21 strains
representative of the genetic, ecological, and geograph-
ical diversity of these species revealed a high level of
synteny across the genomes and no major rearrange-
ments (48). Strains of dairy origin had a prevalence of
accessory genes with high homology (at protein level) to
those detected in L. fermentum, another species com-
monly found in milk, while plant isolates showed the
most diverse repertoire of genes coding orthologs with
high amino acid identity to species commonly found
in other plant isolates. These observations suggested
the contribution of niche-associated gene exchange
to the composite nature of L. casei/L. paracasei, also
supported by the detection of a polycistronic region as-
sociated with lifestyle adaptation with high nucleo-
tide identity with genomic regions in L. plantarum and
L. brevis, and a polycistronic cluster for L(+)-tartrate
catabolism and malate transport in L. casei/L. paracasei
wine isolates with high identity with the same cluster in
L. plantarum. Similar to other lactobacilli, horizontal
gene transfer has been the dominant force in adapta-
tion of these two species to new habitats and lifestyle in
combination with the evolution of genetically distinct
clusters shaped by extensive decay of genes associated
with carbohydrate utilization (48).
Focusing more on probiotic factors, the analysis of
the genomic intraspeciﬁc diversity of 34 other strains
(dairy, plant, and human isolates) revealed the presence
in the L. casei/L. paracasei core genome of several fac-
tors associated with host-microbe interactions such as
cell-envelope proteinase, hydrolases p40 and p75, and
the capacity to produce short branched-chain fatty acids
(bkd operon), which could have an active part in the
complex cross talk between bacterial strains and human
or animal gut. A particular interest derived from the bkd
operon, because the branched-chain fatty acids con-
tribute to the preservation of the integrity of the colonic
epithelium, inhibition of inﬂammation, and modulation
of energy metabolism; the “ﬁtness advantage” coming
from this feature for the strains was provided by the
generation of ATP from amino acid metabolism under
anaerobic conditions in protein-rich anaerobic environ-
ments (51).
Lactobacillus crispatus
Strains belonging to L. crispatus have been isolated
from the gastrointestinal tract of humans and animals,
from the oral cavity, and, above all, from the urovaginal
tract, where it counts for more than 80% of all vaginal
bacteria (52). As the major component, L. crispatus
contributes to the maintenance of the healthy vaginal
microbiota, and its absence is correlated with several
vaginal diseases (i.e., bacterial vaginosis). The beneﬁcial
effects described for this species include reduction of
recurrent urinary tract infections and bacterial vaginosis
in women and the inhibition in vitro of the growth,
viability, and adhesion of uropathogens, suggesting a
role for L. crispatus in protecting the vagina from in-
vading pathogens (53, 54).
The intraspeciﬁc diversity of L. crispatus was inves-
tigated by mining the genome sequences of 10 strains
(nine vaginal isolates and one from chicken cecum) (55),
which revealed a general collinearity and synteny inter-
rupted only by 5 to 21 genomic islands. These regions
were rich in metabolism and EPS biosynthesis genes,
prophages, and adaptive immunity traits, pointing to a
role for these acquired elements in the adaptation of
L. crispatus to varying habitats. The genomic ﬁtness
related to the adaptation to the vaginal environment
was also reﬂected in the type of CRISPR/Cas systems,
which were different between the vaginal isolates and
the chicken isolate, and also by the presence of genes
encoding enzymatic pathways for the utilization of car-
bohydrates (such as mannose) available in the vagina
(56).
A total of 103 proteins with adhesion- and host col-
onization-related domains and 30 putative S-layer pro-
tein-encoding genes were also identiﬁed, along with six
strain-speciﬁc adhesins, and a sortase-anchored protein
with multiple mucus-binding domains.
All the strains under investigation were found to
possess genes for antimicrobial substance production,
including three to four L-lactate dehydrogenase loci,
hydrogen peroxide-encoding genes, and sets of putative
bacteriocin gene clusters, including two regions coding
bacteriolysins. The promotion of the vaginal health
may also beneﬁt from the presence in the core genome
of components with the same mucin- and ﬁbronectin-
binding domains of their counterparts produced by
vaginal pathogens such as Gardnerella vaginalis, thus
actively interfering with the adhesion of these pathogens
to the vaginal mucosa.
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The comparative genomics analysis of the 10 L. cris-
patus strains provided novel information on their
adaptation to the vaginal environment as well as the
factors for the competitive exclusion of pathogens, this
unveiling the mechanisms at the basis of the role of this
species in the maintenance of vaginal health (55).
Lactobacillus delbrueckii
L. delbrueckii is one of the most used lactic acid bacteria
related to dairy food production, where, among others,
the subspecies bulgaricus has been historically applied
for yogurt production in protocooperation with Strep-
tococcus thermophilus, while the subspecies lactis has
been traditionally used for cheese making (57).
Yogurt is considered a nutritious, natural, and safe
component of a healthy diet and it is at the basis of
probiotic concept. Up to now, yogurt is the only func-
tional food product for which a health claim has been
validated in Europe, related to the attenuation of lac-
tose intolerance. In addition, both L. delbrueckii subsp.
bulgaricus and S. thermophilus were found to be corre-
lated with immune modulation and diarrhea-alleviating
effects (58).
The ﬁrst complete genome sequence of L. delbrueckii
subsp. bulgaricus showed a high number of rRNA and
tRNA genes, a signal of a phase of genome size reduc-
tion, a higher GC content at codon position 3, sup-
porting an evolution toward high GC content genome,
and the loss of superﬂuous amino acid biosynthesis
functions, which could be correlated to the adaptation to
the protein-rich milk habitat (58).
The comparative genomics analysis of three strains
of L. delbrueckii subsp. bulgaricus revealed that the
three genomes shared a high number of genes encoding
putative proteases or peptidases, which are essential for
efﬁcient utilization of environmental proteins, along
with an aminotransferase, contributing to the transfer
of branched-chain amino acids into corresponding
α-keto acids, which are known to have cheesy ﬂavors.
Among stress tolerance genes, which are essential for
industrial fermentation adaptation, a thioredoxin sys-
tem (composed by two thioredoxin reductases and two
thioredoxins) was found, along with a peptide methio-
nine sulfoxide reductase, the genes associated with
cell membrane biogenesis and extracellular housekeep-
ing proteases, which confer stability at low pH and are
assumed to play an important role in L. delbrueckii
subsp. bulgaricus oxygen tolerance and acid response
(59).
The subsp. lactis is distinguished from subsp. bulgar-
icus by its more extensive carbohydrate-metabolizing
capability, such as sugars of vegetal-origin like maltose,
mannose, saccharose, and trehalose.
The comparative genomic analysis of 10L. delbrueckii
strains (5 belonging to subsp. lactis and 5 to subsp.
bulgaricus) revealed that L. delbrueckii subsp. bulgaricus
genomes were smaller (1,810 to 1,872 kb) than those
of subsp. lactis strains (1,844 to 2,125 kb) (57). This
difference was linked to the presence of a higher number
of IS elements in subsp. lactis than in subsp. bulgaricus.
The genomes of both subspecies showed an aberrant GC
content at the third codon position in coding sequences
(already observed for subsp. bulgaricus), a high number
of pseudogenes, and a tendency toward elimination of
genes involved in amino acid biosynthesis and carbohy-
drate metabolism, thus reﬂecting an ongoing evolution
and the adaptation to a protein-rich environment. The
analysis of genes related to carbohydrate metabolism
revealed that, in contrast to subsp. lactis, subsp. bulgar-
icus can only metabolize mannose in addition to the milk
sugar lactose, thus showing a more advanced adaptation
to the milk medium. A key adaptation to the milk envi-
ronment is the presence of the major cell wall-bound
protease PrtB responsible for the ﬁrst step in the degra-
dation of milk proteins in both subspecies, while it is not
found in closely related lactobacilli.
An acquired lactose-galactose antiporter to import
the milk sugar lactose was another important feature in
all the strains examined (which is the transport system of
choice in a lactose-rich environment), while the ancestral
dedicated phosphotransferase system (PTS) (which ex-
cels in conditions where the substrate concentration
is low) was detected only in L. delbrueckii subsp. lactis
(57). This suggests the evolution of the ancestral or-
ganism in the mammalian digestive tract, an environ-
ment where both conditions are met. This observation is
also consistent with the fact that most of the known
closely related lactobacilli are gut isolates and with the
presence of genes coding for putative mucus-binding
proteins in the majority of L. delbrueckii subsp. lactis
strains under study.
Since subsp. bulgaricus is historically faster and more
reliable in milk fermentation than the subsp. lactis,
the similarity of their genomes indicates that the indus-
trially relevant differences between the two subspecies
are likely found in gene regulation rather than gene
content (57).
Lactobacillus fermentum
L. fermentum is an obligate heterofermentative lactic
acid bacterium that is usually isolated in fermented food
and in the gastrointestinal tract of humans and animals.
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To date, two L. fermentum strains are commercially
available, namely CECT 5716 and ME-3, which were
shown to reduce inﬂammation and intestinal damage
in vivo, to improve the effects of inﬂuenza vaccination in
healthy volunteers, and to have antioxidative properties
(60–62).
To date, no extensive analysis of the genomic intra-
speciﬁc diversity related to the probiotic traits has been
performed for this species. However, interesting infor-
mation can be collected from the study by Archer and
colleagues (63) where, in the framework of a project
aiming to study the probiotic potential of a panel of acid-
and bile-tolerant strains, 12 L. fermentum strains (three
from infant feces and nine from homemade curd) were
found to harbor genes coding for a bile salt hydrolase, a
ﬁbronectin-binding protein, a mucin-binding protein, a
sortase, and an ATP-binding substrate protein, which
also showed 100% similarity both in fecal and dairy
strains (63).
In addition, the description of four L. fermentum
genomes (strains 3872, MTCC 8711, CECT 5716, and
F-6) allowed the detection of genes coding for mucus-
and collagen-binding proteins, bile salt hydrolases, and
proteins involved in EPS production, likely involved in
the adhesion mechanisms (64, 65).
A recent picture of the general genomic diversity of
this species can be depicted by the MLST derived from
203 L. fermentum isolates from different regions and
products, which indicated that this species had a clonal
population structure and its evolutionary history is not
correlated with geography or food type (66).
Lactobacillus gasseri
L. gasseri belongs to the L. acidophilus complex and it is
usually found in several sites of the human body, such as
the mouth, intestines, feces, or vagina. Strains of this
species are considered as members of the human intes-
tinal “probiome,” which includes commensal intestinal
bacteria with beneﬁcial effects on human health (67).
Genome sequencing of strain ATCC 33323T, of human
origin, allowed the detection of a high number of genes
coding for proteins predicted to be essential in the gas-
trointestinal tract, such as bile salt hydrolases, bile trans-
porters and drug resistance traits, cell surface structures,
2CRSs and other transcriptional regulators, luxS, bac-
teriocin and restriction/modiﬁcation systems and traits
involved in sugar transport and metabolism, oxalate deg-
radation (reducing the incidence of disorders related to
high levels of oxalic acid in the urine), and stress resistance.
Recently, the genome sequences of four vaginal
L. gasseri strains were compared, showing a total of
122 protein families shared by all four strains but
absent in other vaginal species. Traits reﬂecting orga-
nismal interactions were elucidated, such as an addic-
tion module toxin, a toxin-antitoxin addiction module
regulator, and a protein of the toxin-antitoxin system
AbrB family; the genomes also harbored a pediocin
immunity protein, a signal transduction histidine kinase
regulating citrate and malate metabolism, and strain-
speciﬁc aminotransferases, transcriptional regulators,
and inner permeases. The presence of unique proteins
not detected in other vaginal lactobacilli suggested that
this species has experienced lineage-speciﬁc gene gain
and loss.
Because this comparative genomics is only based
on four vaginal strains, the combined analysis of an in-
creasing number of genome sequences of strains within
the same species will help to delineate species-speciﬁc
genes that inﬂuence the ecological and evolutionary
dynamics of this species (68).
Lactobacillus johnsonii
L. johnsonii is a natural inhabitant of the gastrointesti-
nal tracts of several hosts, including humans, mice, dogs,
poultry, pigs, and honeybees.
The probiotic-associated activities reported for this
species are, among others, pathogen inhibition in the
chick gut, alleviation of diabetes symptoms, reduction
of serum cholesterol levels, immunostimulation, and
adhesion to intestinal epithelial cells (69)
The genome sequence of L. johnsonii NCC533,
a human isolate extensively studied for its probiotic
properties, showed that this commensal strain was de-
ﬁcient in biosynthesis of amino acids, purine nucleotides,
and cofactors, but it harbored, in compensation, an im-
pressive array of transporters, peptidases, and proteases,
along with PTS sugar transporters and β-galactosidases,
indicating a reliance on mono-, di-, and trisaccharides
for its fermentative metabolism and a major adaptation
in the upper gastrointestinal tract, where amino acids,
peptides, and lower-order oligosaccharides are abun-
dant. Further metabolic cassettes for saccharide metab-
olism, cell surface proteins, bile salt hydrolases and bile
transporters were identiﬁed (69).
Phenotypic analysis and CGH analysis between this
strain and the type strain of the species, L. johnsonii
ATCC 33200T, showed a lower intestinal persistence
in ATCC 33200T and allowed the detection of 233
NCC533-speciﬁc genes associated with the long-gut-
persistence phenotype including surface proteins and
translocases, PTS transporters, bacteriocin, and proteins
involved in EPS synthesis (26).
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Although an extensive comparative genomic analysis
between L. johnsonii strains is yet to be reported, a large
survey of 39 isolates from fecal-bacterial populations
of a few host species was performed with the Simple
Sequence Repeats assay and MLST analysis that re-
solved the isolates into three clusters, according to their
hosts (chickens, humans, or mice) (70). These data sug-
gest a phylogenetic separation paralleling host speciﬁcity
that arose as a result of coevolution of the host and its
gastrointestinal tract microbiota.
The bacterial-host speciﬁcity identiﬁed in L. johnsonii
constitutes an interesting element to be considered for
the selection of health-promoting speciﬁc strains based
on the microorganisms and host genetics (70).
Lactobacillus plantarum
L. plantarum is one of the most widely known Lacto-
bacillus species because of its distribution in a variety
of environmental niches (many types of fermented
foods, and human body), its versatility, and its metabolic
capacity, which facilitates its use in several industrial
settlings, either as starter cultures or probiotics. The
probiotic properties related to this species are mainly
linked to health promotion in humans and animals, and
members of this species were found to reduce the con-
centration of cholesterol and ﬁbrinogen and the risk of
cardiovascular diseases and atherosclerosis (71).
L. plantarum WCFS1 was the ﬁrst sequenced Lac-
tobacillus genome (20). It harbored traits for stress
response and gastrointestinal tract survival, substrate
utilization and respiration, quorum sensing and bacte-
riocin production, host interaction (with the epithelial
barrier as well as with the immune system), modulation
of cell shape or surface properties, and interaction with
food components and other microorganisms (72).
The comparative genomics analysis based on six strains
showed a very high conservation of gene order and se-
quence identity of orthologs; however, a variety of highly
variable regions were detected which mostly included
(i) prophages, IS elements and transposases (highly diverse
both in gene content and insertion position); (ii) the
plantaricin (L. plantarum-associated bacteriocin) bio-
synthesis cluster (composed by highly conserved genes
together with less conserved traits); (iii) the CPS/EPS
biosynthesis genes; and (iv) the sugar lifestyle cassettes
(accumulated within their lifestyle adaptation region).
An additional extent of diversity was provided by the
presence of numbers of repeated domains, particularly in
extracellular proteins (such as adhesins or membrane-
anchored protein), which play a role in the interactions
between strains and their environment.
These data suggested that the genome diversity of
L. plantarum is high and explain its ﬂexibility and ver-
satility, which allow this species to succeed in diverse
niches and applications. In particular, the presence of
genomic islands containing mosaic cassettes of (likely
laterally acquired) carbohydrate-metabolism genes in-
dicates the development of a “natural metabolic engi-
neering approach” by L. plantarum strains that allows
them to optimize their genomes for growth in speciﬁc
niches (73).
The genome sequences of 54 L. plantarum strains
isolated from different food sources and natural hosts
(as human and insect) (74) revealed a high genetic con-
servation for orthologous groups involved in energy
metabolism, or biosynthesis or degradation of cellular
structural components, such as nucleotides, proteins,
lipids; however, high variability was shown in regions
including genes involved in EPS biosynthesis, restric-
tion modiﬁcation, sugar-importing PTS and other
transport functions, sugar metabolism, and bacteriocin
production, as well as elements like prophages, insertion
sequences, and transposases. The analysis of the gene
content related to the origin of the strain indicated that
gene distribution poorly reﬂected strain origin, different
from what was already observed for other lactobacilli
such as L. reuteri and L. rhamnosus.
The absence of niche specialization (74) showed that
L. plantarum did not undergo the process of bacterial
adaptation to speciﬁc environments, because it acquired
and retained functional capabilities independently of its
niche, representing a typical example of a “nomadic”
bacterial species.
Lactobacillus reuteri
L. reuteri is autochthonous to several vertebrates because
members of this species are isolated from mammalian
and avian gastrointestinal tracts, human urogenital tract,
and breast milk. It showed several strain-speciﬁc bene-
ﬁcial properties relevant to human health including,
for example, the production of essential B complex
vitamins (folate, cobalamin, thiamin, and riboﬂavin) and
antimicrobial compounds (i.e., reuterin); in addition,
L. reuteri is considered a model organism for studying
host-symbiont interactions as well as microbe-host co-
evolution. Lineage-speciﬁc genomic differences were
revealed by the multilocus sequence analysis (MLSA)
of more than 100 strains, reﬂecting the niche charac-
teristics in the gastrointestinal tract of respective hosts.
Interestingly, human-derived L. reuteri strains clustered
in two distinct MLSA clades; one of them (namely clade
II) is related speciﬁcally to humans, while strains in
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the other (clade VI) are closely related to isolates from
chickens (75).
To gain insight into the distinguishing features of
human-derived L. reuteri strains, comparative genomic
analysis performed on 10 strains from three host origins
(human, rat, and pig) unveiled two distinct popula-
tions in L. reuteri and, among human isolates, the
same two clades (clades II and VI) observed with the
MLSA. This observation led to the hypothesis that
the two human-derived clades had been shaped by dif-
ferent evolutionary forces, since they were as dissimilar
to one another as they were to clades that contained
rodent- or porcine-derived strains. The two clades, in
fact, were characterized by (i) the presence of clade-
speciﬁc mobile genetic elements (as two complete
prophages in clade II genomes and clade-speciﬁc trans-
posase families), (ii) distinct metabolic functions and
probiotic phenotypes (clade-speciﬁc order and compo-
sition of genes related to arginine catabolism mechanism
and folate production); (iii) diverse rate of production
of reuterin, which was enhanced in clade VI strains;
(iv) the presence of clade speciﬁc of the transcriptional
PocR (which gene cluster showed only 80% of identity
between clade II and clade VI); (v) the differential effects
on cytokine production by human myeloid cells exposed
to strain supernatants; (vi) the histamine production by
L. reuteri clade II strains that corresponded with anti-
inﬂammatory properties.
These differences reﬂected the distinct ecology of
these strains and the symbiotic relations they establish
and maintain with their hosts. Clade II strains were
all from human fecal samples and they did not cluster
with isolates from other hosts, suggesting these mem-
bers as part of the autochthonous L. reuteri popula-
tion in the human intestinal tract; conversely, strains
in clade VI clustered with poultry strains, and thus they
might be allochthonous to humans originating from
poultry.
As for the non-human isolates, the host speciﬁcity
of L. reuteri in the mouse gut is mediated by speciﬁc
adhesins and other adaptation factors including the
urease cluster, an IgA protease, and genes involved
in bioﬁlm formation (76). This speciﬁcity was sup-
ported by experiments in gnotobiotic mice, which
demonstrated that only rodent strains colonized mice
efﬁciently.
These data provided new hints related to host-
microbe relationship, and they also highlighted the
impact of distinct evolutionary paths within the same
species, which determine howmicrobes act on the ﬁtness
of their hosts (77).
Lactobacillus rhamnosus
L. rhamnosus is commonly found in a variety of eco-
logical habitats, including artisanal and industrial
dairy products, the oral cavity, the intestinal tract,
and the vagina. This species includes the allegedly best-
characterized probiotic strain, namely L. rhamnosus
GG, which displays a wide array of probiotic properties
including the reduction of diarrhea, atopic eczema, and
respiratory infections (78).
Its genome sequence, released in 2006, showed the
presence of genes for three secreted LPXTG-like pilins
(spaCBA) and a pilin-dedicated sortase that is essential
for mucus interaction, likely explaining its ability to
persist in the human intestinal tract (79).
An extensive comparative and functional analysis
based on 100 strains showed the presence of two geno-
phenotypic groups (namely A and B): group A clustered
strains which lack of spaCBA pili, a different car-
bohydrate metabolism proﬁle (they could assimilate
D-lactose, D-maltose, and L-rhamnose) and a distinct
CRISPR system, indicative of the adaptation to a dairy-
like environment; conversely, group B included strains
characterized by a speciﬁc set of traits that confer more
competitive ﬁtness to the intestinal tract, such as bile
resistance, pilus production, and L-fucose metabolism.
Based on these data, strains of group B, which were
also very similar to L. rhamnosus GG, are likely to be
autochthonous in the gastrointestinal tract, and thus
actively exert beneﬁcial effects on it (80).
Further information derived from the comparative
genomic analysis of two phylogenetically related mar-
keted probiotic strains, L. casei BL23 and L. rhamnosus
GG, unveiled a high degree of synteny, interrupted
only by genomic islands with prophages, transposases,
and sugar transport systems, conﬁrming again the
role of horizontal gene transfer in bacterial evolution.
Shared proteins included the identical spaCBA-srtC gene
cluster, which was also found in other L. casei strains.
Conversely from L. rhamnosus strains, none of L. casei
strains produced pili, despite the high level of conser-
vation and sequence identity. This could be explained
by the transcriptional start site of the spaCBA operon,
which was characterized by the presence of an IS ele-
ment in L. rhamnosus strains (but absent in L. casei
strains) that triggers the expression of pili, conferring
on L. rhamnosus strains a beneﬁcial trait to colonize
and persist in mucosa-associated niches (81).
A further comparative genomic analysis based on
40 strains of L. rhamnosus from various niches (mostly
fermented foods and human-associated niches) provided
a better understanding of the variome-associated genes
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and their distribution in terms of metabolic and regula-
tory diversity. Furthermore, horizontal gene transfer
events were detected in some strains or clades that
involved genes related to carbohydrate transport and
catabolism functions, EPS biosynthesis, bacteriocin pro-
duction, restriction modiﬁcation systems, and bacterial
defense systems (CRISP-Cas) together with other ele-
ments that reﬂect niche adaptation such as the diversity
of extracellular functions putatively involved in host
interactions (i.e., cell adhesion or host immune system
modulation) (82).
Lactobacillus sakei
L. sakei is a psychotrophic lactic acid bacterium found
naturally on fermented plant material, meat products,
and ﬁsh. This microorganism is widely known for its
biotechnological potential in biopreservation and food
safety rather than probiotic properties (which were
assessed for strains isolated from the human gut [83]),
and it is used as a starter culture for the controlled pro-
duction of fermented meats.
The analysis of the ﬁrst genome sequence produced
(L. sakei 23K) showed a combination of several fea-
tures used by the organism to adapt and grow in meat
products rather than in the gastrointestinal tract, such as
the ability to exploit purine nucleosides, abundant in
meat, for growth and energy production, and to degrade
arginine when carbon sources are lacking; a versatile
redox metabolism, combined with iron and heme ac-
quisition and the capability to produce bioﬁlm, allows
this microorganism to withstand oxidative stresses and
proliferate on meat surfaces (84).
A CGH approach in combination with fermenta-
tion proﬁle analysis of 10 and, more recently, 18 strains
of L. sakei (taking strain 23K as a reference) mainly
revealed that the features observed in 23K are dis-
tributed also in the other strains of different origin,
and they constitute the common gene pool invariant
of this species. Interestingly, the clustering based on
carbohydrate-fermentation patterns divided the panel
of strains into two phenotypic groups that were not
consistent with the two genetic groups that emerged
with the genome hybridization. In addition, several rrn
clusters were observed in all strains and they can be
related to the ability of an organism to achieve faster
doubling times, suggesting the rapid adaptation by
this microorganism to changing environmental condi-
tions. No differences were detected between the strains
belonging to the two L. sakei subspecies, suggesting
that niche-speciﬁc genes are components of L. sakei
pangenome (83, 85).
Lactobacillus salivarius
L. salivarius is a natural resident of the oral cavity and
the gastrointestinal tract of both humans and animals,
and it has been also isolated from human breast milk.
The probiotic properties of members of this species in-
clude the immunomodulatory effects in cell lines, mice,
rats, and humans and the ability to inhibit pathogens,
alleviating intestinal disease and promoting host well-
being (86).
The ﬁrst genome sequence available for this species
was that from strain UCC118 in 2006, a strain isolated
from the terminal ileum of a healthy patient that has
been extensively studied for its beneﬁcial properties both
in human trials and animal models. The genome com-
prised a circular chromosome, a megaplasmid, and two
plasmids. Genes responsible for the synthesis (de novo
or by interconversion) of nine amino acids and exo-
polysaccharides were identiﬁed both on the chromo-
some and on the plasmids, as well as genes related to
the central carbohydrate metabolism and transport, in-
cluding also those of the pentose phosphate pathway.
This indicated for the ﬁrst time that L. salivarius should
be grouped among the facultatively heterofermentative
instead of homofermentative lactobacilli (87), a feature
that was also conﬁrmed phenotypically. In addition,
the megaplasmid harbored the genes encoding a two-
component class IIb bacteriocin, namely Abp118, which
is protective against the invasive foodborne pathogen
Listeria monocytogenes (88). Taken together, all these
data indicated how the presence of a multireplicon ge-
nome architecture contributed to the metabolic ﬂexibil-
ity and adaptation of L. salivarius UCC118 to dietary
ﬂuctuations and the varying environments encountered
in the gastrointestinal tract of different hosts (89).
The genome diversity of L. salivarius was explored
applying MLST and CGH on a collection of 33 strains
derived from different ecological niches, with diverse
plasmid content and phenotypic traits. The hybrid-
ization signals identiﬁed 18 regions characterized by
variable traits mainly related to niche adaptation and
survival, and they included transposases, bacteriophage
genes, CRISPR loci, EPS biosynthesis, and carbohy-
drate metabolism. Interestingly, the pseudogene number
was very different among the panel of strains, suggesting
genome decay and an ongoing adaptation within the
species. Three major clusters were observed, but they
were not consistent with the isolation sources: however,
most of the animal-associated isolates clustered together
by hierarchical analysis of EPS cluster I and II, whose
distribution in the genomes added an additional extent
of diversity among the strains (28).
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Data reported by Raftis and colleagues showed that
the level of diversity in L. salivariuswas higher than that
in L. plantarum and L. casei, which was also related to
the limited clustering of strains from the same origins, as
well as the poor correlation with complex phenotypes
(as EPS production) (28).
THE CONTROVERSY IN
LACTOBACILLUS TAXONOMY
Understanding and ascribing the beneﬁcial effect of
particular strains of lactobacilli to the species level is
challenging because of the poor correlation between the
phylogenetic relationship and the physiological proper-
ties of Lactobacillus species (13). Since its description
by Beijerinck in 1901, the genus Lactobacillus has dra-
matically expanded in membership, often resulting in
signiﬁcant taxonomic changes, causing confusion and
leading to the misidentiﬁcation of lactobacilli (90).
As already mentioned, the most updated phylogeno-
mic analysis based on 73 core proteins of 175 Lacto-
bacillus species showed a high molecular diversity that is
far too broad to encompass a single well-deﬁned genus,
reﬂected by the DNA GC content and phenotypic di-
versity (12).
An ongoing multilocus sequence typing and network
analysis in our laboratory based on 29 ribosomal pro-
teins and 12 established phylogenetic markers in 238
genomes of Lactobacillus and related genera (namely
Pediococcus, Leuconostoc, Weissella, Fructobacillus,
and Oenococcus) conﬁrms that genus Lactobacillus is
polyphyletic, intermixed with the other genera of family
Lactobacillaceae and Leuconostocaceae and character-
ized by a complex evolutionary history (Salvetti et al.,
in preparation). The combination of sequence-based
(phylogeny) and distance-based methods, namely, the
average nucleotide identity (ANI), the average amino
acid identity (AAI) and the percentage of conserved
proteins (POCP), reveals the presence of 10 consistent
subclades whose suitability to be nuclei of novel genera
is being substantiated through the ongoing investigation
of clade-speciﬁc genes and other conventional taxo-
nomic data.
Members of these groups have been shaped by similar
evolutionary events and are characterized by patterns
of presence/absence of speciﬁc sets of genes that may
be used as novel tools for their characterization. The
absence, in fact, of a discriminative phenotypic feature
supports the description of novel genera starting from
the genotypic subclusters. This represents the most co-
herent driving force available to improve the taxonomic
description of the genus and to prevent Lactobacillus
from a never-ending expansion.
The creation of more uniform taxonomic nuclei
within the Lactobacillus genus will also prevent mis-
identiﬁcation issues that are still the major cause of
mislabeling of probiotic food products reported world-
wide (91). The determination of the genus, the species,
and the strain contained in a probiotic product is the
ﬁrst essential requirement for a novel food marketing
authorization and a health claim submission (92). Tax-
onomic characterization provides, in fact, information
regarding the main physiological, metabolic, beneﬁcial,
and safety properties of the organism.
In addition, unravelling the taxonomic relatedness
of health-promoting lactobacilli together with the analy-
sis of the mechanisms by which they adapt to speciﬁc
environments will provide a new framework for the se-
lection of innovative beneﬁcial microbes.
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